Last edition
News about "Pelage Pharma"
Pelage Pharma Raises USD 120 Million to Advance Regenerative Hair Loss Therapy
Pelage Pharmaceuticals, a Los Angeles-based clinical-stage regenerative medicine company, has raised USD 120 million in a Series B funding round to accelerate the development of its innovative treatment for hair loss. The financing was co-led by ARCH Venture Partners and GV (formerly Google Ventures), with participation from existing investors.
Pelage Pharma | 17/10/2025 | By Darshana | 194
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy